Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., April 1, 2013 – Astellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that James (Jim) Robinson has been named President of...
Read more about Astellas Pharma US, Inc. Names New President
Event is part of the PGA TOUR's Women's Initiative, sponsored by Astellas, and is expected to attract more than 200 women DORAL, Fla. and NORTHBROOK, Ill., March 5, 2013 /PRNewswire/ -- The PGA...
PALM BEACH GARDENS, Fla. and NORTHBROOK, Ill., Feb. 26, 2013 /PRNewswire/ --The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:...
Oncologic Drugs Advisory Committee Meeting Scheduled for May 2, 2013 CAMBRIDGE, Mass. and NORTHBROOK, Ill., February 27, 2013 - AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Global Development,...
San Francisco, CA and Northbrook, IL – February 25, 2013 – Medivation Inc. (Nasdaq: MDVN) and Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503),...
Follow U.S. news
